Views & Analysis Pharma improves HCP engagement during COVID-19 – report Pharma companies have improved how they engage with healthcare providers as a result of COVID-19, according to a new survey of HCPs.
Views & Analysis What HCPs think about pharma For a long time, I have been observing how healthcare professionals (HCPs) are talking about the pharmaceutical industry – including their conversations about how the pharmaceutical industr
News New data build case for Roche's oral BTK drug for MS Roche remains confident in the prospects for its soon-to-be-filed oral BTK drug fenebrutinib for multiple sclerosis, despite safety concerns.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.